Navigation Links
Baron & Budd Attorney Denyse Clancy Speaks at International Mesothelioma Program's First Annual Harvard Medical School Course
Date:7/7/2008

DALLAS, July 7 /PRNewswire/ -- Denyse Clancy, an attorney and shareholder with the Dallas-based law firm Baron & Budd, P.C., spoke at the International Mesothelioma Program's First Annual Harvard Medical School Course, entitled Surgery-Based Multimodality Therapy for Malignant Pleural Mesothelioma. The program was held in Dallas on June 13 and 14.

The program was designed to update thoracic surgeons and other medical professionals about current diagnostic criteria and treatment options available for patients with pleural mesothelioma, a rare, asbestos-related cancer that attacks the lung's lining. It was co-sponsored by the American Association for Thoracic Surgery.

Ms. Clancy spoke with the group of medical professionals about how medical research articles are understood and applied in the courtroom -- sometimes in ways not intended by the scientist authors. Her words provoked lively discussion among the doctors and research scientists present, including questions about the scientific community's responsibility to anticipate the legal applications of their words.

Baron & Budd has a long-standing relationship with the International Mesothelioma Program (IMP). As a member of the IMP's Executive Advisory Board, the law firm is in regular contact with the IMP to remain abreast of mesothelioma research updates affecting treatment options. Baron & Budd was invited to become a member the Executive Board because of our experience and commitment to working with people with mesothelioma. Baron and Budd was the first and remains the longest-standing member of the IMP Executive Advisory Board.

About Baron & Budd, P.C.

Since 1977, the law firm of Baron & Budd, P.C. has championed the rights of people and communities harmed by corporate misconduct. With 49 attorneys and offices in Texas, California and Louisiana, Baron & Budd enjoys a national reputation as a leader of the plaintiffs' bar. The firm represents individuals with mesothelioma and other diseases caused by asbestos; leukemia caused by benzene; injuries caused by other toxic substances and unsafe pharmaceuticals; water authorities seeking clean-up costs for drinking water contamination; securities investors defrauded by corporate wrongdoing; and consumers in class actions.

Susan Knape, 1-244-521-3605 sknape@baronbudd.com


'/>"/>
SOURCE Baron & Budd, P.C.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Asbestos Verdict Upheld by Louisiana Court of Appeal, Announces Baron & Budd
2. Former Texas Assistant Attorney General Pat OConnell Joins Baron & Budd, P.C., to Lead Whistleblower Litigation Practice
3. Baron & Budd, P.C., Announces $3.6 Million Settlement in California Asbestos Lawsuit
4. California Attorney Robert A. Brenner Launches The Burn Injury Law Group to Aid Burn Victims Nationwide
5. Blue Cross Blue Shield of Michigan Responds to Attorney Generals Complaint, Says Transaction Was Legal and Fully Authorized
6. L.A. City Attorney Rocky Delgadillo, Patient Activists to Unveil New Television Ad Targeting Health Insurers
7. Prepared Remarks of Attorney General Michael B. Mukasey on the Justice Departments Efforts to Combat Healthcare Fraud Nationwide
8. Attorney General Michael B. Mukasey to Deliver Keynote Address at Naturalization Ceremony and Remarks on Nationwide Efforts to Combat Healthcare Fraud
9. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Express Scripts Inc.
10. Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx
11. Wage Complaint Forwarded to Attorney General for Prosecution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... Sharon Kleyne, host of the nationally ... on VoiceAmerica sponsored by Nature’s Tears® EyeMist® recently talked on the air about an ... China. , The article by Zidor Aldama described the situation in which Chinese children ...
(Date:7/24/2017)... CUMBERLAND, PA (PRWEB) , ... July 24, 2017 ... ... by 2030, today CURE announced that they have enrolled over 100,000 children in ... 158,000 afflicted children born every year in areas where treatment is limited or ...
(Date:7/24/2017)... ... July 24, 2017 , ... Advanced Dermatology, P.C. ... York, (516) 784-5858. The office opened earlier this summer and is currently accepting ... Fruma Leah Wiederman. , Advanced Dermatology, P.C. founder and medical director Dr. ...
(Date:7/24/2017)... ... ... The Center for Addiction Recovery Training (CART), the training ... Multiple Pathways of Recovery Conference on October 23-26, 2017. This year, the conference ... principle – a belief in multiple pathways of recovery, aims to bring many ...
(Date:7/23/2017)... CANADA (PRWEB) , ... July 23, 2017 , ... ... of single sport specialization is critical, say researchers presenting their work today at ... Toronto, Canada. , “Our study is the first one to prospectively document ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... July 13, 2017  New York City-based market research firm ... should be aware of.  From new products to new costs, ... in a recently completed study, Potential Pipeline Disruptors . ... 1.  Age-Driven Growth - True Impact ... aware of the impact the growing population and, to a ...
(Date:7/11/2017)... , July 11, 2017  The global market ... revenues of approximately $394.1 million in 2016.  Although in ... of solid growth, in particular as a result of ... practice, and the recent introduction of a significant number ... for less-invasive testing of tumor biomarkers to guide treatment ...
(Date:7/10/2017)... , July 10, 2017 The Institute ... test methods, is the recipient of a VITROCELL® inhalation ... PETA International Science Consortium. The device, which is designed ... to expose human lung cells to airborne test materials ... will use the VITROCELL® system for testing combustible tobacco ...
Breaking Medicine Technology: